Samuel Hanlon

Samuel joined the lab in 2026 as a first-year medical student at Trinity College Dublin, with interests in the pathophysiology of mitochondrial dysfunction in neurodegenerative disease. His summer research focused on the co-toxicity mechanisms by which micro/nanoplastics, in combination with viruses and pharmaceuticals, contribute to neurodegeneration. He is passionate about continuing this research and translating his findings into clinical practice.